This week I joined 112 other pro-life leaders in signing a crucially important letter to HHS Secretary Robert F. Kennedy Jr. and Martin A. Makary, M.D., Commissioner of the FDA.
Here’s what we told them.
The most comprehensive analysis of chemical abortion pills shows nearly 11% of women who take this
toxic medicine suffered serious adverse complications.
In addition, one in 20 women require a second abortion attempt. Why? Because a common complication with chemical abortion is an incomplete abortion—that is, parts of the baby and/or placenta are left behind in the womb.
This opens the door to sepsis or other life-threatening infections.
Women are needlessly being placed directly in harm’s way, and we know why.
In cooperation with the Obama and Biden administrations the FDA eliminated crucial medical safeguards for women having chemical abortions. Original researchers were adamant that the protections now jettisoned were absolutely critical in protecting women.
Our letter pointed out that the FDA’s purpose is to safeguard the health and safety of Americans. Furthermore, it helps “the public get the accurate, science-based information they need…to maintain and improve their health.” Yet a growing body of evidence indicates these pills are unacceptably dangerous to women.
We encouraged HHS Secretary Kennedy and FDA Commissioner Makary to place the safety of women over the extreme politics of the abortion industry.
They are in an excellent position to thoroughly and impartially examine the dangers chemical abortion poses to women and act quickly to remedy any threats to their health or lives.
You can help educate others to the documented dangers of chemical abortion pills as well as the science behind abortion pill reversal. Simply sharing this information with the people around you may literally save a life.
Standing with women,
Brad Mattes,
President, Life Issues Institute
Leave a Reply